IMNM - Immunome - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMNM is currently covered by 9 analysts with an average price target of $35. This is a potential upside of $17.08 (95.31%) from yesterday's end of day stock price of $17.92.

Immunome's activity chart (see below) currently has 31 price targets and 42 ratings on display. The stock rating distribution of IMNM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.74% with an average time for these price targets to be met of 174.77 days.

Highest price target for IMNM is $40, Lowest price target is $30, average price target is $35.

Most recent stock forecast was given by ANDRES MALDONADO from HC WAINWRIGHT on 10-Sep-2026. First documented stock forecast 27-Oct-2020.

Currently out of the existing stock ratings of IMNM, 17 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Feb-2026

$40

$23.53 (142.87%)

$40

1 months 11 days ago
(10-Sep-2026)

0/2 (0%)

$15.03 (60.19%)

Buy Since 18-Dec-2023

$35

$18.53 (112.51%)

$31

2 months 9 days ago
(12-Aug-2026)

2/10 (20%)

$7.01 (25.04%)

14

Buy Since 02-Apr-2025

$30

$13.53 (82.15%)

$32

7 months 16 days ago
(04-Mar-2026)

1/3 (33.33%)

$9.05 (43.20%)

258

Buy Since 08-Nov-2024

$30

$10.04 (50.30%)

$33

7 months 17 days ago
(04-Mar-2026)

0/4 (0%)

$7.48 (33.21%)

Buy Since 05-Sep-2025

$36

$16.04 (80.36%)

$33

7 months 17 days ago
(04-Mar-2026)

1/3 (33.33%)

$13.48 (59.86%)

150

Show more analysts

Please expand the browser size to see the chart

What is IMNM (Immunome) average time for price targets to be met?

On average it took 175 days for the stock forecasts to be reached, with an average price target met ratio of 44.74%.

Which analyst most recently updated their price target on IMNM (Immunome)?

Andres Maldonado

Which analyst has the most public recommendations on IMNM (Immunome)?

Andres Maldonado has 9 price targets and 5 ratings on IMNM

Which analyst is the currently most bullish on IMNM (Immunome)?

Andres Maldonado with the highest potential upside of $23.53

Which analyst is the currently most reserved on IMNM (Immunome)?

Matthew Barcus with the lowest potential downside of -$8.47
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?